MediSense commences secondary offering.

WALTHAM, Mass.--(BUSINESS WIRE)--Feb. 17, 1995--MediSense Inc. (NASDAQ/NMS: MSNS) announced that yesterday it had commenced a public offering of 5,320,000 shares of common stock at a price of $20.50 per share.

Of the shares being offered, 50,000 shares are being sold by the company and 5,270,000 shares are being sold by certain selling stockholders. The managing underwriters for the offering are Smith Barney Inc., Alex. Brown & Sons Inc., Goldman, Sachs & Co. and Piper Jaffray Inc. An over-allotment option of 798,000 shares has been provided by certain of the selling stockholders.

MediSense develops, manufactures and markets blood glucose monitoring systems that enable people with diabetes to manage their disease more effectively. Its products are marketed worldwide and are manufactured by the company in facilities located in Abingdon, England and Waltham, Mass.

Copies of the prospectus can be obtained from Smith Barney Inc., 388 Greenwich St., New York 10013.

CONTACT: MediSense

John H. Chiricotti, 617/895-6007